Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Life Sciences
Improving The Selective Cancer Killing Ability Of Zno Nanoparticles Using Fe Doping, Aaron Thurber, Denise Wingett, John Rasmussen, Janet Layne, Lydia Johnson, Dmitri Tenne, Jianhui Zhang, Charles Hanna, Alex Punnoose
Improving The Selective Cancer Killing Ability Of Zno Nanoparticles Using Fe Doping, Aaron Thurber, Denise Wingett, John Rasmussen, Janet Layne, Lydia Johnson, Dmitri Tenne, Jianhui Zhang, Charles Hanna, Alex Punnoose
Lydia Johnson
This work reports a new method to improve our recent demonstration of zinc oxide (ZnO) nanoparticles (NPs) selectively killing certain human cancer cells, achieved by incorporating Fe ions into the NPs. Thoroughly characterized cationic ZnO NPs (∼6 nm) doped with Fe ions (Zn(1-x )Fe (x) O, x = 0-0.15) were used in this work, applied at a concentration of 24 μg/ml. Cytotoxicity studies using flow cytometry on Jurkat leukemic cancer cells show cell viability drops from about 43% for undoped ZnO NPs to 15% for ZnO NPs doped with 7.5% Fe. However, the trend reverses and cell viability increases with …
Epigenetic Modification As An Enabling Mechanism For Leukemic Transformation, Vincent Sollars
Epigenetic Modification As An Enabling Mechanism For Leukemic Transformation, Vincent Sollars
Vincent E Sollars
Cancer is now thought of as a fundamentally genetic disease, in that changes in the genome result in aberrant gene expression of oncogenes and tumor suppressor genes to promote oncogenesis. However, with our increasing knowledge of gene regulation, it is becoming obvious that changes in nucleotide sequence are not the sole mechanism for eliciting changes in transcription. An additional layer of regulation of gene expression, called epigenetics, is now being realized as increasingly important in oncogenesis. Epigenetics is defined as non-sequence based changes in chromatin that elicit changes in gene expression that are propagated through mitosis and/or meiosis. The alleles …
Diversity In Secreted Pla2-Iia Activity Among Inbred Mouse Strains That Are Resistant Or Susceptible To Apcmin/+ Tumorigenesis, Marina Markova, Revati Koratkar, Karen Silverman, Vincent Sollars, Melina Macphee-Pellini, Rhonda Walters, Juan Palazzo, Arthur Buchberg, Linda Siracusa, Steven Farber
Diversity In Secreted Pla2-Iia Activity Among Inbred Mouse Strains That Are Resistant Or Susceptible To Apcmin/+ Tumorigenesis, Marina Markova, Revati Koratkar, Karen Silverman, Vincent Sollars, Melina Macphee-Pellini, Rhonda Walters, Juan Palazzo, Arthur Buchberg, Linda Siracusa, Steven Farber
Vincent E Sollars
The secreted phospholipase A2 type IIA (Pla2g2a) gene was previously identified as a modifier of intestinal adenoma multiplicity in ApcMin/+ mice. To determine if intestinal secreted phospholipase A2 (sPLA2) activity was also attenuated in susceptible strains, we developed a sensitive assay to directly quantitate sPLA2 activity in the murine intestinal tract utilizing a fluorescent BODIPY-labeled phospholipid substrate. Here, we report assay conditions that distinguish between secreted and cytosolic PLA2 enzyme activities in extracts of intestinal tissue. The small intestine exhibited higher activity levels than the large intestine. Consistent with predictions from the sPLA …
Star Rna-Binding Protein Quaking Suppresses Cancer Via Stabilization Of Specific Mirna, Natalie Farny, An-Jou Chen, Ji-Hye Paik, Hailei Zhang, Sachet Shukla, Richard Mortensen, Jian Hu, Haoqiang Ying, Baoli Hu, Jessica Hurt, Caroline Dong, Yonghong Xiao, Y. Wang, Pamela Silver, Lynda Chin, Shobha Vasudevan, Ronald Depinho
Star Rna-Binding Protein Quaking Suppresses Cancer Via Stabilization Of Specific Mirna, Natalie Farny, An-Jou Chen, Ji-Hye Paik, Hailei Zhang, Sachet Shukla, Richard Mortensen, Jian Hu, Haoqiang Ying, Baoli Hu, Jessica Hurt, Caroline Dong, Yonghong Xiao, Y. Wang, Pamela Silver, Lynda Chin, Shobha Vasudevan, Ronald Depinho
Natalie G. Farny
Multidimensional cancer genome analysis and validation has defined Quaking (QKI), a member of the signal transduction and activation of RNA (STAR) family of RNA-binding proteins, as a novel glioblastoma multiforme (GBM) tumor suppressor. Here, we establish that p53 directly regulates QKI gene expression, and QKI protein associates with and leads to the stabilization of miR-20a; miR-20a, in turn, regulates TGFβR2 and the TGFβ signaling network. This pathway circuitry is substantiated by in silico epistasis analysis of its components in the human GBM TCGA (The Cancer Genome Atlas Project) collection and by their gain- and loss-of-function interactions in in vitro and …